Monday, December 8, 2008

Can Antisense drugs revolutionize the drug discovery ?

Antisense therapy, is an important technology for drug discovery and development. It is broadly used by the pharmaceutical industry as a tool for functional genomics and as highly specific drugs for a wide range of diseases (Anticancer, anti-inflammatory, cardiovascular and neurodegenerative diseases) The most interesting factor of antisense drugs is “specificity” in contrast to the traditional drugs (which binds to the proteins and charge interactions so often ending with undesirable side effects). With the combined efforts of human genome programme and bioinformatics, we may soon have a lesser number of targets, I think this interesting field may revolutionize the drug discovery. But the real concern is, there are a few players as of now. In my opinion, something like High Throughput Screening (HTS), with co-ordination of educational and private institutes may help to have more drug contenders (as for as my knowledge goes, Southern Research Institute, Birmingham did try for antitubercular drugs, for the drug resistant strain). Let us hope, something happen in the near future…..

No comments: